Expert Opinion on Pharmacotherapy, Volume 22, Issue 2 (2021)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Pharmacotherapy, Volume 22, Issue 2 (2021)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Volume 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Editorial

Editorial
Are thiazolidinediones a preferred drug treatment for type 2 diabetes?
Kathryn M. Hurren & Marissa Waldman Dunham
Pages: 131-133
Published online: 07 Dec 2020
First Page PreviewforAre thiazolidinediones a preferred drug treatment for type 2 diabetes? | Full Text | References | PDF (844.6 KB) | EPUB
  • 4187 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access

Drug Evaluation

Article
An evaluation of buparlisib for the treatment of head and neck squamous cell carcinoma
Nicholas Lenze, Bhisham Chera & Siddharth Sheth
Pages: 135-144
Published online: 30 Oct 2020
AbstractforAn evaluation of buparlisib for the treatment of head and neck squamous cell carcinoma | Full Text | References | PDF (1.6 MB) | EPUB
  • 277 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
An overview of sarecycline for the treatment of moderate-to-severe acne vulgaris
Isabel Cristina Valente Duarte de Sousa
Pages: 145-154
Published online: 14 Sep 2020
AbstractforAn overview of sarecycline for the treatment of moderate-to-severe acne vulgaris | Full Text | References | PDF (402.7 KB) | EPUB
  • 251 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Evaluating pitolisant as a narcolepsy treatment option
Stefano de Biase, Gaia Pellitteri, Gian Luigi Gigli & Mariarosaria Valente
Pages: 155-162
Published online: 17 Sep 2020
AbstractforEvaluating pitolisant as a narcolepsy treatment option | Full Text | References | PDF (374.1 KB) | EPUB
  • 537 Views
  • 9 CrossRef citations
  • 0Altmetric

Key Paper Evaluation

Article
Evaluation of cardiovascular and renal outcomes with ertugliflozin: what is the VERdict from the VERTIS-CV trial?
Kevin Cowart & Nicholas W. Carris
Pages: 163-165
Published online: 23 Sep 2020
AbstractforEvaluation of cardiovascular and renal outcomes with ertugliflozin: what is the VERdict from the VERTIS-CV trial? | Full Text | References | PDF (161.8 KB) | EPUB | Supplemental
  • 578 Views
  • 2 CrossRef citations
  • 0Altmetric

Perspective

Therapeutic options for difficult-to-treat Acinetobacter baumannii infections: a 2020 perspective
Matteo Bassetti, Laura Labate, Chiara Russo, Antonio Vena & Daniele Roberto Giacobbe
Pages: 167-177
Published online: 11 Sep 2020
AbstractforTherapeutic options for difficult-to-treat Acinetobacter baumannii infections: a 2020 perspective | Full Text | References | PDF (2.8 MB) | EPUB
  • 455 Views
  • 19 CrossRef citations
  • 0Altmetric

Review

Pharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects
Sandro La Vignera, Antonio Aversa, Rossella Cannarella, Rosita A. Condorelli, Ylenia Duca, Giorgio I. Russo & Aldo E. Calogero
Pages: 179-189
Published online: 09 Sep 2020
AbstractforPharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects | Full Text | References | PDF (431.3 KB) | EPUB
  • 642 Views
  • 14 CrossRef citations
  • 0Altmetric
Pharmacological management of Idiopathic Pulmonary Fibrosis: current and emerging options
Athina Trachalaki, Mujammil Irfan & Athol U Wells
Pages: 191-204
Published online: 29 Sep 2020
AbstractforPharmacological management of Idiopathic Pulmonary Fibrosis: current and emerging options | Full Text | References | PDF (721.5 KB) | EPUB
  • 908 Views
  • 13 CrossRef citations
  • 0Altmetric
State of the art: approved and emerging JAK inhibitors for rheumatoid arthritis
Thomas El Jammal, Pascal Sève, Mathieu Gerfaud-Valentin & Yvan Jamilloux
Pages: 205-218
Published online: 23 Sep 2020
AbstractforState of the art: approved and emerging JAK inhibitors for rheumatoid arthritis | Full Text | References | PDF (1.1 MB) | EPUB
  • 1141 Views
  • 10 CrossRef citations
  • 0Altmetric
The pharmacotherapeutic management of gastroesophageal reflux disease (GERD)
Nicolas Chapelle, Ines Ben Ghezala, Alan Barkun & Marc Bardou
Pages: 219-227
Published online: 07 Sep 2020
AbstractforThe pharmacotherapeutic management of gastroesophageal reflux disease (GERD) | Full Text | References | PDF (377.8 KB) | EPUB
  • 1024 Views
  • 12 CrossRef citations
  • 0Altmetric
Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients
Syed Shahzad Hasan, Chia Siang Kow, Amie Bain, Sallianne Kavanagh, Hamid A. Merchant & Muhammad Abdul Hadi
Pages: 229-240
Published online: 22 Oct 2020
AbstractforPharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients | Full Text | References | PDF (405.8 KB) | EPUB
  • 3551 Views
  • 13 CrossRef citations
  • 0Altmetric
Late phase completed clinical trials investigating bromocriptine mesylate quick release as treatment of type 2 diabetes mellitus
Maka Siamashvili & Stephen Davis
Pages: 241-247
Published online: 08 Oct 2020
AbstractforLate phase completed clinical trials investigating bromocriptine mesylate quick release as treatment of type 2 diabetes mellitus | Full Text | References | PDF (303.7 KB) | EPUB
  • 89 Views
  • 3 CrossRef citations
  • 0Altmetric

Original Research

Article
Real-world data on the use of insulin glargine 300 U/mL in Japanese patients with type 1 diabetes: twelve-month results from a post-marketing surveillance study (X-STAR study)
Munehide Matsuhisa, Masato Odawara, Takahisa Hirose, Ryusuke Koshida, Masayuki Senda, Yasushi Tanaka & Yasuo Terauchi
Pages: 249-256
Published online: 25 Aug 2020
AbstractforReal-world data on the use of insulin glargine 300 U/mL in Japanese patients with type 1 diabetes: twelve-month results from a post-marketing surveillance study (X-STAR study) | Full Text | References | PDF (445 KB) | EPUB | Supplemental
  • 1694 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Explore articles